Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Ovarian Neoplasms

  Free Subscription


Articles published in Eur J Obstet Gynecol Reprod Biol

Retrieve available abstracts of 44 articles:
HTML format
Text format



Single Articles


    March 2018
  1. NTOUMANOGLOU-SCHUIKI A, Tomasch G, Laky R, Taumberger N, et al
    Opportunistic prophylactic salpingectomy for prevention of ovarian cancer: What do national societies advise?
    Eur J Obstet Gynecol Reprod Biol. 2018;225:110-112.
    PubMed     Text format     Abstract available


  2. CAPOTE S, Sanchez-Iglesias JL, Cubo-Abert M, De la Torre J, et al
    Myeloid sarcoma as a simulator of advanced ovarian cancer: A case report.
    Eur J Obstet Gynecol Reprod Biol. 2018 Mar 28. pii: S0301-2115(18)30154.
    PubMed     Text format    


    January 2018
  3. RUAN L, Xie Y, Liu F, Chen X, et al
    Serum miR-1181 and miR-4314 associated with ovarian cancer: MiRNA microarray data analysis for a pilot study.
    Eur J Obstet Gynecol Reprod Biol. 2018;222:31-38.
    PubMed     Text format     Abstract available


    December 2017
  4. UCCELLA S, Gisone B, Stevenazzi G, Ghezzi F, et al
    Laparoscopic sentinel node detection with ICG for early ovarian cancer: Description of a technique and literature review.
    Eur J Obstet Gynecol Reprod Biol. 2017 Dec 6. pii: S0301-2115(17)30543.
    PubMed     Text format    


    October 2017
  5. VERMEULEN CKM, Tadesse W, Timmermans M, Kruitwagen RFPM, et al
    Only complete tumour resection after neoadjuvant chemotherapy offers benefit over suboptimal debulking in advanced ovarian cancer.
    Eur J Obstet Gynecol Reprod Biol. 2017;219:100-105.
    PubMed     Text format     Abstract available


    July 2017
  6. WEN Q, Shao Z, Zhang P, Zhu T, et al
    Mental distress, quality of life and social support in recurrent ovarian cancer patients during active chemotherapy.
    Eur J Obstet Gynecol Reprod Biol. 2017;216:85-91.
    PubMed     Text format     Abstract available


  7. CHENE G, Chauvy L, Buenerd A, Moret S, et al
    Dynamic real-time in vivo confocal laser endomicroscopy of the fallopian tube during laparoscopy in the prevention of ovarian cancer.
    Eur J Obstet Gynecol Reprod Biol. 2017;216:18-23.
    PubMed     Text format     Abstract available


    June 2017
  8. YILDIRIM N, Akman L, Acar K, Demir S, et al
    Do tumor-infiltrating lymphocytes really indicate favorable prognosis in epithelial ovarian cancer?
    Eur J Obstet Gynecol Reprod Biol. 2017;215:55-61.
    PubMed     Text format     Abstract available


    May 2017
  9. GORDTS S, Campo R, Bogers JP, Tanos V, et al
    Transvaginal laparoscopy: A minimally invasive approach to obtain brush cytology of the Fallopian tube.
    Eur J Obstet Gynecol Reprod Biol. 2017;212:80-84.
    PubMed     Text format     Abstract available


    January 2017
  10. SAIJO M, Nakamura K, Masuyama H, Ida N, et al
    Glasgow prognostic score is a prognosis predictor for patients with endometrial cancer.
    Eur J Obstet Gynecol Reprod Biol. 2017;210:355-359.
    PubMed     Text format     Abstract available


    December 2016
  11. GHANEM AI, Khan NT, Mahan M, Ibrahim A, et al
    The impact of lymphadenectomy on survival endpoints in women with early stage uterine endometrioid carcinoma: A matched analysis.
    Eur J Obstet Gynecol Reprod Biol. 2016;210:225-230.
    PubMed     Text format     Abstract available


    November 2016
  12. ROMANOWICZ H, Michalska MM, Samulak D, Malinowski J, et al
    Association of R156R single nucleotide polymorphism of the ERCC2 gene with the susceptibility to ovarian cancer.
    Eur J Obstet Gynecol Reprod Biol. 2016;208:36-40.
    PubMed     Text format     Abstract available


    October 2016
  13. KASPER SM, Dueholm M, Marinovskij E, Blaakaer J, et al
    Imaging diagnostics in ovarian cancer: magnetic resonance imaging and a scoring system guiding choice of primary treatment.
    Eur J Obstet Gynecol Reprod Biol. 2016;210:83-89.
    PubMed     Text format     Abstract available


  14. ISROW D, Burmeister C, Hanna RK, Elshaikh MA, et al
    Survival endpoints for young women with early stage uterine endometrioid carcinoma: a matched analysis.
    Eur J Obstet Gynecol Reprod Biol. 2016;207:115-120.
    PubMed     Text format     Abstract available


  15. BAR D, Lavie O, Stein N, Feferkorn I, et al
    The effect of metabolic comorbidities and commonly used drugs on the prognosis of patients with ovarian cancer.
    Eur J Obstet Gynecol Reprod Biol. 2016 Oct 14. pii: S0301-2115(16)30914.
    PubMed     Text format     Abstract available


  16. NI T, Sun X, Shan B, Wang J, et al
    Detection of circulating tumour cells may add value in endometrial cancer management.
    Eur J Obstet Gynecol Reprod Biol. 2016;207:1-4.
    PubMed     Text format     Abstract available


  17. RUIZ M, Labauge P, Louboutin A, Limot O, et al
    External validation of the MR imaging scoring system for the management of adnexal masses.
    Eur J Obstet Gynecol Reprod Biol. 2016;205:115-9.
    PubMed     Text format     Abstract available


    August 2016
  18. RUIZ MP, Morales-Ramirez PB, Dziadek OL, Algren SD, et al
    Epithelial ovarian cancer and type of peritoneal insult: a case-control study.
    Eur J Obstet Gynecol Reprod Biol. 2016;205:170-173.
    PubMed     Text format     Abstract available


    June 2016
  19. RADHOUANE A, Mayada S, Khaled N
    Lymphangioma of the ovary: etiology and management.
    Eur J Obstet Gynecol Reprod Biol. 2016 Jun 29. pii: S0301-2115(16)30296.
    PubMed     Text format     Abstract available


  20. SINHA A, Drews F, Lim K, Pugh ND, et al
    Retrospective analysis of suspicious pelvic masses using the Pelvic Mass Index (PMI) scoring system from 2007 to 2014.
    Eur J Obstet Gynecol Reprod Biol. 2016;201:79-84.
    PubMed     Text format     Abstract available


    May 2016
  21. GURASLAN H, Dogan K
    Management of unilocular or multilocular cysts more than 5 centimeters in postmenopausal women.
    Eur J Obstet Gynecol Reprod Biol. 2016;203:40-43.
    PubMed     Text format     Abstract available


    April 2016
  22. MINIG L, Saadi J, Patrono MG, Giavedoni ME, et al
    Laparoscopic surgical staging in women with early stage epithelial ovarian cancer performed by recently certified gynecologic oncologists.
    Eur J Obstet Gynecol Reprod Biol. 2016;201:94-100.
    PubMed     Text format     Abstract available


    March 2016
  23. SHIBER LJ, Gregory EJ, Gaskins JT, Biscette SM, et al
    Adnexal masses requiring reoperation in women with previous hysterectomy with or without adnexectomy.
    Eur J Obstet Gynecol Reprod Biol. 2016;200:123-127.
    PubMed     Text format     Abstract available


  24. NARIN MA, Karalok A, Basaran D, Ureyen I, et al
    Does synchronous endometrioid endometrial cancer have any prognostic effect on Stage I endometrioid ovarian cancer?
    Eur J Obstet Gynecol Reprod Biol. 2016;200:113-116.
    PubMed     Text format     Abstract available


    February 2016
  25. BUDA A, Ghelardi A, Fruscio R, Guelfi F, et al
    The contribution of a collagen-fibrin patch (Tachosil) to prevent the postoperative lymphatic complications after groin lymphadenectomy: a double institution observational study.
    Eur J Obstet Gynecol Reprod Biol. 2016;197:156-8.
    PubMed     Text format     Abstract available


    November 2015
  26. SECKIN KD, Karsli MF, Yucel B, Bestel M, et al
    The utility of tumor markers and neutrophil lymphocyte ratio in patients with an intraoperative diagnosis of mucinous borderline ovarian tumor.
    Eur J Obstet Gynecol Reprod Biol. 2015;196:60-63.
    PubMed     Text format     Abstract available


    October 2015
  27. TJALMA WA
    Staging classification for cancer of the ovary and the fallopian tube should include in situ carcinoma.
    Eur J Obstet Gynecol Reprod Biol. 2015 Oct 27. pii: S0301-2115(15)00363.
    PubMed     Text format    


    September 2015
  28. KOTOWICZ B, Fuksiewicz M, Sobiczewski P, Spiewankiewicz B, et al
    Clinical value of human epididymis protein 4 and the Risk of Ovarian Malignancy Algorithm in differentiating borderline pelvic tumors from epithelial ovarian cancer in early stages.
    Eur J Obstet Gynecol Reprod Biol. 2015;194:141-146.
    PubMed     Text format     Abstract available


  29. MARTIN-MERINO E, Garcia Rodriguez LA, Wallander MA, Andersson S, et al
    The incidence of hysterectomy, uterus-preserving procedures and recurrent treatment in the management of uterine fibroids.
    Eur J Obstet Gynecol Reprod Biol. 2015;194:147-152.
    PubMed     Text format     Abstract available


    August 2015
  30. PECES RAMA A, Llanos Llanos MC, Sanchez Ferrer ML, Alcazar Zambrano JL, et al
    Simple descriptors and simple rules of the International Ovarian Tumor Analysis (IOTA) Group: a prospective study of combined use for the description of adnexal masses.
    Eur J Obstet Gynecol Reprod Biol. 2015;195:7-11.
    PubMed     Text format     Abstract available


    July 2015
  31. BAE J, Choi JS, Lee WM, Koh AR, et al
    Feasibility and efficacy of laparoscopic restaging surgery for women with unexpected ovarian malignancy.
    Eur J Obstet Gynecol Reprod Biol. 2015;193:46-50.
    PubMed     Text format     Abstract available


    June 2015
  32. REDDIHALLI PV, Subbian A, Umadevi K, Rathod PS, et al
    Immature teratoma of ovary - outcome following primary and secondary surgery: study of a single institution cohort.
    Eur J Obstet Gynecol Reprod Biol. 2015;192:17-21.
    PubMed     Text format     Abstract available


  33. VAN VLIET MM, Schreuder HW, Pasker-de Jong PC, Duk MJ, et al
    Centralisation of epithelial ovarian cancer surgery: results on survival from a peripheral teaching hospital.
    Eur J Obstet Gynecol Reprod Biol. 2015;192:72-78.
    PubMed     Text format     Abstract available


    May 2015
  34. RUIZ DE GAUNA B, Rodriguez D, Olartecoechea B, Auba M, et al
    Diagnostic performance of IOTA simple rules for adnexal masses classification: a comparison between two centers with different ovarian cancer prevalence.
    Eur J Obstet Gynecol Reprod Biol. 2015;191:10-14.
    PubMed     Text format     Abstract available


    March 2015
  35. PRAT J
    Abridged republication of FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum.
    Eur J Obstet Gynecol Reprod Biol. 2015 Mar 7. pii: S0301-2115(15)00081.
    PubMed     Text format    


    January 2015
  36. SOLMAZ U, Mat E, Dereli ML, Turan V, et al
    Lymphovascular space invasion and positive pelvic lymph nodes are independent risk factors for para-aortic nodal metastasis in endometrioid endometrial cancer.
    Eur J Obstet Gynecol Reprod Biol. 2015;186C:63-67.
    PubMed     Text format     Abstract available


  37. VASCONCELOS I, Olschewski J, Braicu I, Sehouli J, et al
    Limited efficacy of platinum-based adjuvant treatment on the outcome of borderline ovarian tumors.
    Eur J Obstet Gynecol Reprod Biol. 2015;186C:26-33.
    PubMed     Text format     Abstract available


    December 2014
  38. CHO YJ, Lee HS, Kim JM, Lee SY, et al
    Ovarian-sparing local mass excision for ovarian fibroma/fibrothecoma in premenopausal women.
    Eur J Obstet Gynecol Reprod Biol. 2014;185C:78-82.
    PubMed     Text format     Abstract available


  39. KADAN Y, Fiascone S, McCourt C, Raker C, et al
    Predictive factors for the presence of malignant transformation of pelvic endometriosis.
    Eur J Obstet Gynecol Reprod Biol. 2014;185C:23-27.
    PubMed     Text format     Abstract available


    October 2014
  40. DI DONATO N, Zanello M, Corti B, Seracchioli R, et al
    Incidental diagnosis of ectopic adenohypophyseal tissue in an ovarian dermoid cyst: a case report.
    Eur J Obstet Gynecol Reprod Biol. 2014 Oct 31. pii: S0301-2115(14)00568.
    PubMed     Text format    


  41. BRUN JL, Fritel X, Aubard Y, Borghese B, et al
    Management of presumed benign ovarian tumors: updated French guidelines.
    Eur J Obstet Gynecol Reprod Biol. 2014;183C:52-58.
    PubMed     Text format     Abstract available


  42. SONG T, Lee YY, Choi CH, Kim TJ, et al
    Borderline ovarian tumor in women aged >/=65 years: impact on recurrence and survival.
    Eur J Obstet Gynecol Reprod Biol. 2014;184C:38-42.
    PubMed     Text format     Abstract available


    August 2014
  43. KODAMA M, Grubbs BH, Blake EA, Cahoon SS, et al
    Feto-maternal outcomes of pregnancy complicated by ovarian malignant germ cell tumor: a systematic review of literature.
    Eur J Obstet Gynecol Reprod Biol. 2014;181C:145-156.
    PubMed     Text format     Abstract available


  44. UREYEN I, Turan T, Cirik DA, Tasci T, et al
    Frozen section in borderline ovarian tumors: is it reliable?
    Eur J Obstet Gynecol Reprod Biol. 2014;181C:115-118.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: